مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Effect of FCGR2A and FCGR3A variants on CLL outcome.
Normal view MARC view ISBD view

Effect of FCGR2A and FCGR3A variants on CLL outcome. [electronic resource]

By:
  • Dornan, David
Contributor(s):
  • Spleiss, Olivia
  • Yeh, Ru-Fang
  • Duchateau-Nguyen, Guillemette
  • Dufour, Annika
  • Zhi, Jianguo
  • Robak, Tadeusz
  • Moiseev, Sergey I
  • Dmoszynska, Anna
  • Solal-Celigny, Philippe
  • Warzocha, Krzysztof
  • Loscertales, Javier
  • Catalano, John
  • Afanasiev, Boris V
  • Larratt, Loree
  • Rossiev, Viktor A
  • Bence-Bruckler, Isabelle
  • Geisler, Christian H
  • Montillo, Marco
  • Wenger, Michael K
  • Weisser, Martin
Producer: 20101221Description: 4212-22 p. digitalISSN:
  • 1528-0020
Subject(s):
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived -- pharmacokinetics
  • Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
  • Cyclophosphamide -- therapeutic use
  • Disease-Free Survival
  • Female
  • Genotype
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell -- diagnosis
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide -- genetics
  • Prognosis
  • Receptors, IgG -- genetics
  • Rituximab
  • Treatment Outcome
  • Vidarabine -- analogs & derivatives
Online resources:
  • Available from publisher's website
In: Blood vol. 116
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Effect of FCGR2A and FCGR3A variants on CLL outcome.

APA

Dornan D., Spleiss O., Yeh R., Duchateau-Nguyen G., Dufour A., Zhi J., Robak T., Moiseev S. I., Dmoszynska A., Solal-Celigny P., Warzocha K., Loscertales J., Catalano J., Afanasiev B. V., Larratt L., Rossiev V. A., Bence-Bruckler I., Geisler C. H., Montillo M., Wenger M. K. & Weisser M. (20101221). Effect of FCGR2A and FCGR3A variants on CLL outcome. : Blood.

Chicago

Dornan David, Spleiss Olivia, Yeh Ru-Fang, Duchateau-Nguyen Guillemette, Dufour Annika, Zhi Jianguo, Robak Tadeusz, Moiseev Sergey I, Dmoszynska Anna, Solal-Celigny Philippe, Warzocha Krzysztof, Loscertales Javier, Catalano John, Afanasiev Boris V, Larratt Loree, Rossiev Viktor A, Bence-Bruckler Isabelle, Geisler Christian H, Montillo Marco, Wenger Michael K and Weisser Martin. 20101221. Effect of FCGR2A and FCGR3A variants on CLL outcome. : Blood.

Harvard

Dornan D., Spleiss O., Yeh R., Duchateau-Nguyen G., Dufour A., Zhi J., Robak T., Moiseev S. I., Dmoszynska A., Solal-Celigny P., Warzocha K., Loscertales J., Catalano J., Afanasiev B. V., Larratt L., Rossiev V. A., Bence-Bruckler I., Geisler C. H., Montillo M., Wenger M. K. and Weisser M. (20101221). Effect of FCGR2A and FCGR3A variants on CLL outcome. : Blood.

MLA

Dornan David, Spleiss Olivia, Yeh Ru-Fang, Duchateau-Nguyen Guillemette, Dufour Annika, Zhi Jianguo, Robak Tadeusz, Moiseev Sergey I, Dmoszynska Anna, Solal-Celigny Philippe, Warzocha Krzysztof, Loscertales Javier, Catalano John, Afanasiev Boris V, Larratt Loree, Rossiev Viktor A, Bence-Bruckler Isabelle, Geisler Christian H, Montillo Marco, Wenger Michael K and Weisser Martin. Effect of FCGR2A and FCGR3A variants on CLL outcome. : Blood. 20101221.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site